Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 9 hrs

S&P Futures
5,886.50
-9.75(-0.17%)
Dow Futures
43,121.00
-56.00(-0.13%)
Nasdaq Futures
20,471.50
-48.00(-0.23%)
Russell 2000 Futures
2,249.70
-5.80(-0.26%)
Crude Oil
70.43
-0.13(-0.18%)
Gold
2,749.50
+10.60(+0.39%)

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

3.1100

-0.0500

(-1.58%)

At close: 04:00PM EDT

3.1100

0.00

(0.00%)

After hours:

04:02PM EDT

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	412.31M
Enterprise Value	435.28M
Trailing P/E	72.75
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.92
Price/Book (mrq)	1.56
Enterprise Value/Revenue	0.97
Enterprise Value/EBITDA	32.78

Trading Information

Stock Price History

Beta (5Y Monthly)	1.60
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	4.7050
52 Week Low ³	1.9600
50-Day Moving Average ³	2.8364
200-Day Moving Average ³	2.9488

Share Statistics

Avg Vol (3 month) ³	574.74k
Avg Vol (10 day) ³	524.45k
Shares Outstanding ⁵	132.57M
Implied Shares Outstanding ⁶	N/A
Float ⁸	59.76M
% Held by Insiders ¹	32.88%
% Held by Institutions ¹	47.82%
Shares Short (Sep 30, 2024) ⁴	10.44M
Short Ratio (Sep 30, 2024) ⁴	21.49
Short % of Float (Sep 30, 2024) ⁴	29.25%
Short % of Shares Outstanding (Sep 30, 2024) ⁴	7.87%
Shares Short (prior month Aug 30, 2024) ⁴	13.99M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	-3.69%
Operating Margin (ttm)	6.84%

Management Effectiveness

Return on Assets (ttm)	1.94%
Return on Equity (ttm)	-6.19%

Income Statement

Revenue (ttm)	448.39M
Revenue Per Share (ttm)	3.40
Quarterly Revenue Growth (yoy)	11.00%
Gross Profit (ttm)	N/A
EBITDA	30.01M
Net Income Avi to Common (ttm)	-16.55M
Diluted EPS (ttm)	-0.1200
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	89.9M
Total Cash Per Share (mrq)	0.68
Total Debt (mrq)	112.87M
Total Debt/Equity (mrq)	42.83
Current Ratio (mrq)	2.73
Book Value Per Share (mrq)	1.99

Cash Flow Statement

Operating Cash Flow (ttm)	21.92M
Levered Free Cash Flow (ttm)	22.45M